Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fortin

Showing results (151-160 of 329) with videos related to

Pageof 33
Sort By:
The Journal of Rheumatology|October 3, 2014
Transitioning to employment with a rheumatic disease: the role of independence, overprotection, and social supportArif Jetha, Elizabeth Badley, Dorcas Beaton, et al.
Rheumatology (Oxford, England)|December 16, 2010
Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosusWendy Zhang, Elaheh Aghdassi, Heather N Reich, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 6, 2007
Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay methodBruno Fautrel, Ann E Clarke, Francis Guillemin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2005
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?Carlo A Marra, Amir A Rashidi, Daphne Guh, et al.
Arthritis Care & Research|December 28, 2020
Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision-Making in Systemic Lupus Erythematosus Treatment?Celline C Almeida-Brasil, Christian A Pineau, Evelyne Vinet, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1986
L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonistR N Young, Y Guindon, T R Jones, et al.
Medicine|March 1, 1997
A controlled study of diffuse idiopathic skeletal hyperostosis. Clinical features and functional statusS Mata, P R Fortin, M A Fitzcharles, et al.
The Journal of Rheumatology|November 1, 1993
Chest radiographs as a screening test for diffuse idiopathic skeletal hyperostosisS Mata, R O Hill, L Joseph, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4R N Young, T R Jones, J G Atkinson, et al.
Arthritis Research & Therapy|October 8, 2016
A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritisCarolina Landolt-Marticorena, Stephenie D Prokopec, Stacey Morrison, et al.
Pageof 33

Showing results (151-160 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Rheumatology|October 3, 2014
Transitioning to employment with a rheumatic disease: the role of independence, overprotection, and social supportArif Jetha, Elizabeth Badley, Dorcas Beaton, et al.
Rheumatology (Oxford, England)|December 16, 2010
Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosusWendy Zhang, Elaheh Aghdassi, Heather N Reich, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 6, 2007
Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay methodBruno Fautrel, Ann E Clarke, Francis Guillemin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2005
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?Carlo A Marra, Amir A Rashidi, Daphne Guh, et al.
Arthritis Care & Research|December 28, 2020
Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision-Making in Systemic Lupus Erythematosus Treatment?Celline C Almeida-Brasil, Christian A Pineau, Evelyne Vinet, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1986
L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonistR N Young, Y Guindon, T R Jones, et al.
Medicine|March 1, 1997
A controlled study of diffuse idiopathic skeletal hyperostosis. Clinical features and functional statusS Mata, P R Fortin, M A Fitzcharles, et al.
The Journal of Rheumatology|November 1, 1993
Chest radiographs as a screening test for diffuse idiopathic skeletal hyperostosisS Mata, R O Hill, L Joseph, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4R N Young, T R Jones, J G Atkinson, et al.
Arthritis Research & Therapy|October 8, 2016
A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritisCarolina Landolt-Marticorena, Stephenie D Prokopec, Stacey Morrison, et al.
Pageof 33